EUVIMEDEUVIMED entdecken
ValidierungsstudieBeobachtungsstudieOpen Access · CC BY 4.0

External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients

Nicolai K Kristensen, Laurens Manning, Jeppe Lange, Joshua S Davis

The Journal of Arthroplasty · 2024

DOI: 10.1016/j.arth.2024.03.070 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Nicolai K Kristensen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Regional Hospital of Horsens, Horsens, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Cente…. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Periprosthetic joint infection (PJI) is a devastating complication in hip and knee joint arthroplasty. The "Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH)" classification system was developed in 2021 to stratify the complexity of PJI, and more importantly, to act as a tool to guide referrals to specialist centers. The "JS-BACH" classification has not been validated in an external cohort. This study aimed to do so using a large prospective cohort from Australia and New Zealand. METHODS: We applied the JS-BACH classification to the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort. This prospective study of newly diagnosed PJI collected 2-year outcome data from 653 participants enrolled in 27 hospitals. The definition of PJI treatment failure at 24 months was any of the following: death, clinical or microbiological signs of infection, destination prosthesis removed, or ongoing antibiotic use. Individual cases were classified as per JS-BACH into "1: uncomplicated" (n = 268), "2: complex" (n = 330), and "3: limited options" (n = 55). This cohort was similar to the original JS-BACH population in terms of baseline characteristics. However, there was a difference in complexity, with more debridement, antibiotics, and implant retention procedures, fewer revision procedures, and a higher proportion of uncomplicated patients in the PIANO cohort. RESULTS: The risk of treatment failure correlated strongly with the JS-BACH category, with odds ratios (95% confidence interval) for category 2 versus 1 of 1.75 (1.24 to 2.47) and for category 3 versus 1 of 7.12 (3.42 to 16.02). CONCLUSIONS: Despite the PIANO study population being less complicated than the original derivation cohort, the JS-BACH classification showed a clear association with treatment failure in this large external cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, KneeArthroplasty, Replacement, HipAnti-Bacterial AgentsHumansFemaleMaleAgedProspective StudiesMiddle AgedNew ZealandAustraliaHip ProsthesisAged, 80 and overKnee ProsthesisCohort StudiesReoperation

Stichwörter der Autor:innen

arthroplastyclassificationhip replacementknee replacementperiprosthetic joint infectionrevision

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Orthopedics, Regional Hospital of Horsens, Horsens, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Center for Planned Surgery, Regional Hospital of Silkeborg, Silkeborg, Denm…
  • Medical School, University of Western Australia, Perth, Western Australia, Australia; Department of Infectious Diseases, Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Department of Orthopedics, Regional Hospital of Horsens, Horsens, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Infection Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.

Zitieren

APA

Kristensen, N. K., Manning, L., Lange, J., & Davis, J. S. (2024). External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.03.070

Vancouver

Kristensen NK, Manning L, Lange J, Davis JS. External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2024.03.070

BibTeX
@article{Kristensen2024,
  author = {Kristensen, Nicolai K and Manning, Laurens and Lange, Jeppe and Davis, Joshua S},
  title = {External Validation of the Joint-Specific Bone Involvement, Antimicrobial Options, Coverage of the Soft Tissues, and Host Status (JS-BACH) Classification for Predicting Outcome in Periprosthetic Joint Infections: A Cohort of 653 Patients},
  journal = {The Journal of Arthroplasty},
  year = {2024},
  doi = {10.1016/j.arth.2024.03.070}
}
Kostenlos starten →